Re: Enzalutamide in metastatic prostate cancer before chemotherapy: Editorial comment

Samir S. Taneja

doi:10.1016/j.juro.2014.08.040

Re: Enzalutamide in metastatic prostate cancer before chemotherapy: Editorial comment

Samir S. Taneja

Biomedical Engineering

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	1419
Number of pages	1
Journal	Journal of Urology
Volume	192
Issue number	5
DOIs	https://doi.org/10.1016/j.juro.2014.08.040
State	Published - Nov 1 2014

ASJC Scopus subject areas

Urology

Access to Document

10.1016/j.juro.2014.08.040

Cite this

@article{4e3c8fac7fd04d7b9d671555d838793f,

title = "Re: Enzalutamide in metastatic prostate cancer before chemotherapy: Editorial comment",

author = "Taneja, {Samir S.}",

year = "2014",

month = nov,

day = "1",

doi = "10.1016/j.juro.2014.08.040",

language = "English (US)",

volume = "192",

pages = "1419",

journal = "Journal of Urology",

issn = "0022-5347",

publisher = "Elsevier Inc.",

number = "5",

}

TY - JOUR

T1 - Re

T2 - Enzalutamide in metastatic prostate cancer before chemotherapy: Editorial comment

AU - Taneja, Samir S.

PY - 2014/11/1

Y1 - 2014/11/1

UR - http://www.scopus.com/inward/record.url?scp=84910028860&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84910028860&partnerID=8YFLogxK

U2 - 10.1016/j.juro.2014.08.040

DO - 10.1016/j.juro.2014.08.040

M3 - Comment/debate

AN - SCOPUS:84910028860

SN - 0022-5347

VL - 192

SP - 1419

JO - Journal of Urology

JF - Journal of Urology

IS - 5

ER -

Re: Enzalutamide in metastatic prostate cancer before chemotherapy: Editorial comment

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this